Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Ceapro Inc > New Press Release - Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2052)
•••
Comment by lscfaon May 29, 2024 10:22am
82 Views
Post# 36062213

RE:RE:RE:New Press Release - Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

RE:RE:RE:New Press Release - Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateBase biz barely cash flow positive


 

CFO b/f legal & R&D

 

439,733

Q1 24

(361,227)

Q4 23

744,074

Q3 23

265,473

Q2 23

1,079,425

Q1 23

1,076,037

Q4 22

3,447,652

Q3 22

3,222,223

Q2 22

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities